Site icon Brief News

Mylan, U.S. finalize $465 million EpiPen settlement

EpiPen

Mylan finalizes settlement with the U.S. Justice Department, resolving claims it overcharged the government for its EpiPen.

CBC | Health News

Exit mobile version